© Shutterstock
Zafar Nausherwaan, Germany
We’ve all read books or seen movies set in dystopian worlds, where secret underground labs have developed unconventional treatments for post-apocalyptic diseases. Imagine vast halls filled with large tubes containing humanoid figures that suddenly become conscious, able to feel and think like humans. While such scenarios remain in the realm of fiction, there are scientific advancements that are real, remarkable and worth discussing: Organoids, tiny models of human organs replicating many functions of their full-sized counterparts.
An organoid is a miniature version of an organ, grown in vitro in three dimensions, that faithfully mimics key functions and structures of its full-sized counterpart. Organoids are tiny, three-dimensional clusters of cells that proliferate in a lab dish and behave like miniature human organs, such as the liver, pancreas, and intestines. In other words, they act as mini-organs—stand-ins for full-sized ones—used in research to study biology and disease more accurately than two-dimensional cell cultures. [1]
Scientists start by harvesting stem cells – special cells that can become almost any other cell type in the body. [1] Under carefully controlled conditions (specific nutrients, growth factors, and a supportive three-dimensional matrix), these stem cells self-organise into structures that mimic real organs. Over time, they form various cell types found in the organ of interest, recreating its basic architecture and function.
You might wonder: why develop organoids when you can work with flat, two-dimensional cell cultures? Three-dimensional organoids allow us to study diseases and test new treatments with far greater precision, because they recapitulate the complex architecture and cell-to-cell interactions found in real tissues. Flat cultures grow cells in a single layer, missing many important features of living organs; organoids restore those features, making lab results more predictive of human responses.
By growing organoids from a patient’s own cells, researchers can test different therapies in the lab – reducing guesswork and avoiding unnecessary side effects. For example, doctors can harvest a small sample of a patient’s tumour, derive mini-tumour organoids, and screen various chemotherapy drugs to find the most effective regimen for that individual’s genetic profile. This personalised medicine approach cuts down on trial-and-error, delivering treatments tailored to each patient’s unique disease. [2, 3]
Because organoids come from human cells, they also offer a more ethical alternative to animal testing – and they often predict human drug responses more accurately. Researchers can screen medicines on human-like tissues, sparing animals from experiments and speeding up the path from lab discovery to clinical trials. As protocols improve, organoids may one day repair damaged tissues or even grow whole organs for transplant—offering hope to patients with chronic or terminal diseases and those waiting for donor matches in registries worldwide. [4, 5]
Over the years, organoids have already led to major scientific breakthroughs that demonstrate their power. For instance, nerve organoids are being developed from a patient’s own tissue, grown